MyMD Pharmaceuticals Inc (NAS:MYMD)
$ 1.9 0.09 (4.97%) Market Cap: 4.50 Mil Enterprise Value: 2.74 Mil PE Ratio: 0 PB Ratio: 0.42 GF Score: 37/100

MyMD Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jul 31, 2023 / 02:00PM GMT
Release Date Price: $43.5 (+31.82%)
Operator

Welcome to the Annual Meeting of Stockholders for MyMD Pharmaceuticals, Inc. Our host for today's call is Dr. Chris Chapman, President, Director, and Chief Medical Officer. (Operator Instructions)

I will now turn the call over to your host. Dr. Chapman, you may begin.

Chris Chapman
MyMD Pharmaceuticals, Inc. - President, Director, & Chief Medical Officer

Good morning, ladies and gentlemen. I'm Chris Chapman, President, Director, and Chief Medical Officer of MyMD Pharmaceuticals. I welcome you to our annual meeting of stockholders.

I would like to start by introducing the directors and officers of the company: Mr. Joshua Silverman, Director and Chairman of the Board; Dr. Craig Eagle, Director; Mr. Christopher C. Schreiber, Director; Mr. Jude Uzonwanne, Director; Mr. Bill J. White, Director; Dr. Adam Kaplin, Chief Scientific Officer; Mr. Ian Rhodes, Chief Financial Officer; Mr. Paul Rivard, Chief Legal Officer.

I will conduct and act as Chairman of this meeting. I hereby call the meeting to order. Mr. Paul Rivard has been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot